<DOC>
	<DOC>NCT00852202</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy, safety, and tolerability of cariprazine in the treatment of outpatients with bipolar depression.</brief_summary>
	<brief_title>Safety and Efficacy of RGH-188 (Cariprazine) in Bipolar Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>Men and women, 1865 years old Currently meet the DSMIVTR criteria for Bipolar I or II Disorder without psychotic features, with a current depressive episode A verified previous manic, hypomanic, or mixed episode Score of 20 or higher on the HAMD17 Score of 2 or higher on Item 1 of the HAMD Score greater than 12 on the Young Mania Rating Scale Eight or more episodes of a mood disturbance (depression, mania, hypomania, or mixed state) within the 12 months prior to Visit 1 Principal DSMIVTRbased diagnosis of an axis I disorder other than bipolar disorder (a secondary diagnosis of comorbid Generalized Anxiety Disorder, Social Anxiety Disorder, or specific phobias is acceptable)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>bipolar</keyword>
	<keyword>depression</keyword>
</DOC>